Literature DB >> 3914622

Some considerations in the design of a nutrition intervention trial in Linxian, People's Republic of China.

W J Blot, J Y Li.   

Abstract

Various issues pertaining to the design of a nutrition intervention trial in Linxian, a county in North Central China where esophageal cancer rates are extraordinarily high among a population with chronic deficiencies of multiple nutrients, are addressed. Two target populations are identified: One is a group of patients diagnosed with severe esophageal dysplasia, the other is the general population of the high-risk area. Interventions involving the supplementation of each group with vitamins and minerals are described, and a rationale is provided for the selection of nutrients and choice of dose levels. Several potential statistical designs are evaluated, with particular emphasis on the balancing of gains in specificity afforded by full and fractional factorial designs against their potential loss in sensitivity compared with the simplest design involving a placebo versus a multiple vitamin and mineral supplement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3914622

Source DB:  PubMed          Journal:  Natl Cancer Inst Monogr        ISSN: 0083-1921


  20 in total

Review 1.  Magnifying endoscopy in upper gastroenterology for assessing lesions before completing endoscopic removal.

Authors:  Ning-Li Chai; En-Qiang Ling-Hu; Yoshinori Morita; Daisuke Obata; Takashi Toyonaga; Takeshi Azuma; Ben-Yan Wu
Journal:  World J Gastroenterol       Date:  2012-03-28       Impact factor: 5.742

Review 2.  Nutritional intervention studies in cancer prevention.

Authors:  L E Holm
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of esophageal squamous cell carcinoma.

Authors:  Zhanjun Guo; Hua Yang; Fengbin Zhang; Ruixing Zhang; Cuiju Wang
Journal:  Oncol Lett       Date:  2011-11-25       Impact factor: 2.967

Review 4.  Epidemiology of Esophageal Squamous Cell Carcinoma.

Authors:  Christian C Abnet; Melina Arnold; Wen-Qiang Wei
Journal:  Gastroenterology       Date:  2017-08-18       Impact factor: 22.682

5.  Genetic polymorphisms of microRNA machinery genes predict overall survival of esophageal squamous carcinoma.

Authors:  Cuiju Wang; Hailing Dong; Haiyan Fan; Jianhua Wu; Guiying Wang
Journal:  J Clin Lab Anal       Date:  2017-12-11       Impact factor: 2.352

6.  Relevance of serum estradiol and estrogen receptor beta expression from a high-incidence area for esophageal squamous cell carcinoma in China.

Authors:  Qi-Ming Wang; Yi-Jun Qi; Qi Jiang; Yuan-Fang Ma; Li-Dong Wang
Journal:  Med Oncol       Date:  2010-03-02       Impact factor: 3.064

7.  Prospective study of serum cysteine levels and oesophageal and gastric cancers in China.

Authors:  Gwen Murphy; Jin-Hu Fan; Steven D Mark; Sanford M Dawsey; Jacob Selhub; Jianbing Wang; Philip R Taylor; You-Lin Qiao; Christian C Abnet
Journal:  Gut       Date:  2011-01-17       Impact factor: 23.059

Review 8.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

9.  Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey.

Authors:  Z He; Y Zhao; C Guo; Y Liu; M Sun; F Liu; X Wang; F Guo; K Chen; L Gao; T Ning; Y Pan; Y Li; S Zhang; C Lu; Z Wang; H Cai; Y Ke
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

10.  Independent and Joint Associations between Serum Calcium, 25-Hydroxy Vitamin D, and the Risk of Primary Liver Cancer: A Prospective Nested Case-Control Study.

Authors:  Jian Yin; Liang-Yu Yin; Neal D Freedman; Ting-Yuan Li; Sanford M Dawsey; Jian-Feng Cui; Philip R Taylor; Bin Liu; Jin-Hu Fan; Wen Chen; Christian C Abnet; You-Lin Qiao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-08-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.